Thailand has introduced its first domestically created targeted therapy pill for cancer treatment, named Imcranib 100.

Ponatinib improved MRD negativity and safety in Ph+ ALL patients in the PHALLcon study, supporting its role as a potent TKI ...

Italy’s Robin Foà, MD, an iconic European clinician-researcher, has been at forefront of hematology’s transformation for half ...

Thailand has produced its first locally developed targeted therapy pill for cancer treatment. Imcranib 100 is the result of ...